RMED's logo.
Ticker Symbol: RMED

Catheter Precision Inc.

$2.65 - 20-12-2024 4 p.m. ET

Exchange: NYSE MKT LLC Country: US Currency: USD Asset Type: Common Stock CIK:0001716621

Company Profile

Ra Medical Systems commercializes excimer lasers and catheters for the treatment of vascular and dermatological diseases. In May 2017, the DABRA excimer laser system received FDA 510(k) clearance in the U.S. for crossing chronic total occlusions, or CTOs, in patients with symptomatic infrainguinal lower extremity vascular disease with an intended use for ablating a channel in occlusive peripheral vascular disease. The Pharos excimer laser system is FDA-cleared and is used as a tool in the treatment of psoriasis, vitiligo, atopic dermatitis and leukoderma. DABRA and Pharos are both based on Ra Medical's core excimer laser technology platform and deploy similar mechanisms of action. Ra Medical manufactures DABRA and Pharos excimer lasers and catheters in a 32,000-square-foot facility located in Carlsbad, Calif. The vertically integrated facility is ISO 13485 certified and is licensed by the State of California to manufacture sterile, single-use catheters in controlled environments.

Sector: Manufacturing
Industry: Surgical and Medical Instrument Manufacturing
Standard Industrial Classification Code (SIC code): 3841
Address: 2070 Las Palmas Dr
Website: www.ramed.com
CEO: N/A
Tags:
  • Health Technology
  • Medical Specialties
  • Manufacturing
  • Surgical and Medical Instrument Manufacturing

Pricing

Last Updated: December 31, 1969 07:00 PM EST
Previous Close: -
Change: - ( 0.00%)
Days Range: $0.51 - $0.59
Beta: -
52wk. High: $11.14
52wk. Low: $0.51
Ytd. Change -89.92%
50 Day Moving Average: $0.69
200 Day Moving Average: $1.42
Shares Outstanding: 5367674

Valuation

Market Cap: 318.8M
PE Ratio: -
EPS (TTM): 0

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A